SCHEMBL7871597

SCHEMBL7871597

NCC(=O)NC(=O)Oc1ccc(C(=O)NS(=O)(=O)c2ccc(CCNC(=O)C3CCCCC3)cc2)cn1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.44
CYP3A4 P08684 1/20 0.44
HTR1A P08908 1/20 0.44
MAPT P10636 1/20 0.44
CYP2C9 P11712 1/20 0.44
TSHR P16473 1/20 0.44
NFKB1 P19838 1/20 0.44
CNR1 P21554 1/20 0.44
CYP2C19 P33261 1/20 0.44
ADRA1A P35348 1/20 0.44
BLM P54132 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
KMT2A Q03164 5/20 0.40
MEN1 O00255 4/20 0.40
MAPK1 P28482 1/20 0.38
NPC1 O15118 1/20 0.38
HDAC6 Q9UBN7 1/20 0.37
EGFR P00533 1/20 0.37
CA1 P00915 3/20 0.37
CA2 P00918 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7867694 0.90 EPHX2 (0.43) LMNACYP3A4HTR1AMAPTCYP2C9
SCHEMBL7870549 0.88 MAPT (0.47) LMNACYP3A4HTR1AMAPTCYP2C9
SCHEMBL7871341 0.86 MAPT (0.46) LMNACYP3A4HTR1AMAPTCYP2C9
SCHEMBL9018314 0.86 MAPT (0.49) LMNACYP3A4HTR1AMAPTCYP2C9
SCHEMBL7871673 0.86 ACACB (0.43) LMNAKMT2AMEN1EGFRCA1
SCHEMBL7862898 0.85 LMNA (0.47) LMNACYP3A4HTR1AMAPTCYP2C9
SCHEMBL7870460 0.84 MAPT (0.44) LMNACYP3A4HTR1AMAPTCYP2C9
SCHEMBL7867814 0.84 MEN1 (0.48) MAPTSMN1; SMN2KMT2AMEN1NPC1
SCHEMBL9018409 0.84 MAPT (0.49) LMNACYP3A4HTR1AMAPTCYP2C9
SCHEMBL7862712 0.83 EGFR (0.51) MAPTCYP2C19SMN1; SMN2KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0562512-B1 Sulfonamidocarbonylpyridine-2-carboxamides and their use as medicines HOECHST AG (DE) 2001-02-21 EP disclosed
EP-0562512-A1 Sulfonamido- and sulfonamidocarbonyl-pyridine-2-carboxamides and their pyridine-N-oxides, process for their preparation and their use as medicines HOECHST AKTIENGESELLSCHAFT (DE) 1993-09-29 EP disclosed